Local News
Eyewitness Sports
Medical Coverage
Call For Action
More Details
What's On WPRI
What's On Fox
2 Minute Test Drive
Experts Online
Online Store
Chopper 12
Station Info

MARKETPLACE:  Auto | Jobs | People Search | Personals | Travel | Yellow Pages  January 14, 2005
Education | House & Home | Money | Pets | Recipes | Relationships | What's Next | More Topics...
U.S. to Stockpile New Anthrax Vaccine
Email to a Friend Printer Friendly Version  

By Amanda Gardner, HealthDay Reporter

THURSDAY, Nov. 4 (HealthDayNews) -- The U.S. government announced Thursday that it has awarded an $877.5 million contract to a private company to manufacture and deliver 75 million doses of a new vaccine for inhalation anthrax.

The supply, enough to fully vaccinate 25 million people, will go to the Strategic National Stockpile to protect against a bioterrorist attack. The company, VaxGen Inc. of Brisbane, Calif., must deliver the first 25 million doses within two years and the entire 75 million within the following three years.

"This is a critical step forward in our preparedness," U.S. Health and Human Services (HHS) Secretary Tommy Thompson said at a news conference. "This is a key step towards protecting American public in the event of another anthrax attack."

Though it hasn't been tested for its effectiveness, "we have a lot of faith in this vaccine, and we believe it is the right way to move forward to protect the country against anthrax," added Dr. Philip Russell, medical advisor to the HHS.

The conference, which was attended by several other representatives of the government and private industry, was interrupted by queries about whether Thompson would continue at his post during the second Bush administration. He sidestepped them. "All I can tell you is that this is a discussion about anthrax, and [we] will have to talk about my future some other time," Thompson said.

The contract is the first awarded under Project BioShield, inaugurated earlier this year to expedite the development, purchase and availability of medical countermeasures for biological, chemical, radiological and nuclear threats.

"This is visionary legislation," Thompson said. "It is going to make America a lot safer because we are going to be able to encourage companies to get into the business of producing vaccines and drugs and therapies such as this one."

HHS funded development of the vaccine, beginning in September 2002. The military has been conducting research into this particular type of vaccine for about a decade.

The vaccine still needs to go through testing and is not yet licensed by the U.S. Food and Drug Administration.

The vaccine is made using purified recombinant protective antigen, a protein that elicits antibodies against anthrax toxins.

"It's a matter of honing down on the purity of the protein," said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. "It's not making a modified protein. It's just having the DNA technology to be spitting out a whole bunch of purified protein that is essentially identical to what the microbe itself would make if you let it grow in culture. It's a highly efficient and purified way of getting it."

The vaccine will probably be given intramuscularly and will require three doses to become effective, Russell said. "The final clinical studies have not been done to determine the final schedule," he said.

Thompson said the vaccine would be available for emergency use only.

Vaxgen President and CEO Lance Gordon said he anticipated the first delivery to be made at the beginning of 2006. As for when it might be available outside of the government stockpile, "our time line currently anticipates filing for licensure in 2007," he added.

More information

The government has more on Project BioShield (www.hhs.gov ).

SOURCES: Nov. 4, 2004, press conference with Tommy G. Thompson, U.S. Secretary of Health and Human Services; Anthony Fauci, M.D., director, National Institute of Allergy and Infectious Diseases; Lance Gordon, president and CEO, VaxGen Inc.; Philip Russell, M.D., medical advisor, U.S. Department of Health and Human Services

Copyright � 2004 ScoutNews, LLC. All rights reserved.

Health News | Health Encyclopedia | Quizzes and Tools | Women's Health | Men's Health | Children's Health | Seniors' Health | Diet, Fitness and Self Image | Sex and Relationships
Health Encyclopedia: Children's Health
Otitis Media
Otitis Externa
Learning Disabilities
Insect Bites And Stings
Immunizations - Child
Umbilical Hernia In Infants
Precocious Puberty
Reye's Syndrome
Respiratory Syncytial Virus
Children's Health News
U.S. Meeting Demand For Flu Shots... So Far
U.S. to Launch Massive Study Into Children's Health
U.S. to Stockpile New Anthrax Vaccine
Mind the Cars, Not Just the Candy, for a Happy Halloween
Virulent Parasite Yields Genetic Secrets
Uninsured Kids At Higher Risk for Burst Appendix
U.S. Secures Another 2.6 Million Flu Vaccines
U.S. Says No More Flu Vaccine
Flu Shots Will Be Earmarked for Neediest
Youth Not Heeding Antismoking Messages
Is Your Financial House in Order?
Take a look at your New Year's resolution list. Is "make a budget," "save more money," or "start investing" on there? Click now for simple solutions.
What's a Good Credit Score?
It's your right to know what credit scoring agencies are saying about you. Learn what's considered a "good" score.
Living With Diabetes
Part of living with Diabetes is managing it properly. A free Diabetes Health Organizer can help.
Send questions and comments about this website to the .
All content © Copyright 2003-2005 WorldNow, WPRI, WNAC and Associated Press. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.